GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.

Name: GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.
Author: Pereira, Fernando

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. — المؤلف: Pereira, Fernando — BMC cancer 20220517

المؤلف: Pereira, Fernando
النشر: BMC cancer 20220517
الوصف: 536 p.
الموضوعات: Antineoplastic Combined Chemotherapy Protocols؛ Colonic Neoplasms؛ Colorectal Neoplasms؛ Combined Modality Therapy؛ Cytoreduction Surgical Procedures؛ Humans؛ Hyperthermia, Induced؛ Hyperthermic Intraperitoneal Chemotherapy